R
Robert Lanza
Researcher at Astellas Pharma
Publications - 249
Citations - 22146
Robert Lanza is an academic researcher from Astellas Pharma. The author has contributed to research in topics: Embryonic stem cell & Stem cell. The author has an hindex of 65, co-authored 249 publications receiving 21136 citations. Previous affiliations of Robert Lanza include Wake Forest Institute for Regenerative Medicine & Dartmouth College.
Papers
More filters
Journal ArticleDOI
Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins.
Dohoon Kim,Chun-Hyung Kim,Jung-Il Moon,Young-Gie Chung,Mi-Yoon Chang,Baek-Soo Han,Sanghyeok Ko,Eungi Yang,Kwang Yul Cha,Robert Lanza,Kwang Soo Kim +10 more
TL;DR: Document S1.
Book
Principles of tissue engineering
TL;DR: The history and Scope of Tissue Engineering, J.P. Vavanti and C.A. Vacanti, and Quantitative Aspects of Tissues Engineering: Basic Issues in Kinetics, Transport, and Mechanics are reviewed.
Journal ArticleDOI
Embryonic stem cell trials for macular degeneration: a preliminary report
Steven D. Schwartz,Jean-Pierre Hubschman,Gad Heilwell,Valentina Franco-Cardenas,Carolyn K. Pan,Rosaleen Ostrick,Edmund Mickunas,Irina Klimanskaya,Robert Lanza +8 more
TL;DR: The first description of hESC-derived cells transplanted into human patients with Stargardt's macular dystrophy and dry age-related macular degeneration is provided, with no signs of hyperproliferation, tumorigenicity, ectopic tissue formation, or apparent rejection after 4 months.
Journal ArticleDOI
Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies
Steven D. Schwartz,Carl D. Regillo,Byron L. Lam,Dean Eliott,Philip J. Rosenfeld,Ninel Z. Gregori,Jean-Pierre Hubschman,Janet L. Davis,Gad Heilwell,Marc J. Spirn,Joseph I. Maguire,Jane Bateman,Rosaleen Ostrick,Debra Morris,Matthew Vincent,Eddy Anglade,Lucian V. Del Priore,Robert Lanza +17 more
TL;DR: The results suggest that hESC-derived cells could provide a potentially safe new source of cells for the treatment of various unmet medical disorders requiring tissue repair or replacement.
Journal ArticleDOI
Human embryonic stem cell lines derived from single blastomeres
TL;DR: A series of ten separate experiments demonstrating that hES cells can be derived from single blastomeres are reported, which would address the ethical concerns of many, and allow the generation of matched tissue for children and siblings born from transferred PGD embryos.